Transmedics Group IncChange company Symbol lookupSelect an option...TMDX Transmedics Group IncINSG Inseego CorpAVDL Avadel Pharmaceuticals PLCLCSHY Lancashire Holdings LtdNET Cloudflare IncPRCT PROCEPT BioRobotics CorpAAL American Airlines Group IncATXS Astria Therapeutics IncFRGT Freight Technologies IncABNB Airbnb IncGo
TransMedics Group, Inc. is a commercial-stage medical technology company. The Company is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed an organ care system (OCS), a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It designed its OCS technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state. It has developed three OCS products, one each for lung, heart and liver transplantation. Its products include OCS Heart, OCS Lung and OCS Liver. Its OCS product consists of three components customized for each organ, which include the OCS Console, OCS Perfusion Set and OCS Solutions. It is also developing OCS products for additional organs, including kidneys.
Postmarket |
|
|
| ||
Market Hours |
|
|
|
|
|
- Prev Close
- 73.62
- Today's Open
- 74.72
- Day's Range
- 73.00-75.20
- Avg Vol (10-day)
- 310.4K
- Last (time)
- 4:00p ET 03/30/23
- Last (size)
- 383
- 52-Wk Range
20.36 - 83.48- LowHigh
- 52-Wk Range
% Below High
The current share price compared to the 52-week high.
- 11.63%
- Historical Volatility
Historical Volatility
The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.
- 76.2%
- Market Cap
- 2.4B
- Shares Outstanding
- 32.2M
- EPS (TTM, GAAP)
EPS (TTM, GAAP)
GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- -1.25
- P/E Ratio (TTM, GAAP)
P/E Ratio (TTM, GAAP)
GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- --
- Annual Dividend/Yield
Annual Dividend/Yield
Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.
- No dividend
- Ex-dividend Date
- No dividend
- Dividend Pay Date
- No dividend
- Beta
Beta
The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.
- 1.5
- % Held by Institutions
% Held by Institutions
Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.
- 92.08
- Short Interest(% of float 02/28/23)
Short Interest
The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.
- 4.90
Latest News
| February 24, 2023 | |
|---|---|
| 4:05 pm ET | |
| PR Newswire | |
| February 22, 2023 | |
| 4:09 pm ET | |
| PR Newswire | |
| February 21, 2023 | |
| 4:05 pm ET | |
| Globe Newswire | |
| February 08, 2023 | |
| 4:05 pm ET | |
| PR Newswire | |
| February 02, 2023 | |
| 4:08 pm ET | |
| PR Newswire | |
| Go to all current & historical news | |
Events
- 02/22/23
Q4 2022 Transmedics Group Inc Earnings Release - Actual: -$0.21 - 11/03/22
Q3 2022 Transmedics Group Inc Earnings Release - Actual: -$0.25 - 08/01/22
Q2 2022 Transmedics Group Inc Earnings Release - Actual: -$0.41 - 05/03/22
Q1 2022 Transmedics Group Inc Earnings Release - Actual: -$0.38
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.